Presentation of exogenous protein antigens on major histocompatability complex class I molecules by dendritic cells : Pathway of presentation and regulation by cytokinesBROSSART, P; BEVAN, M. J.Blood. 1997, Vol 90, Num 4, pp 1594-1599, issn 0006-4971Article

Expression of MUC-1 epitopes on normal bone marrow : Implications for the detection of micrometastatic tumor cellsBRUGGER, W; BÜHRING, H.-J; SCHEDING, S et al.Journal of clinical oncology. 1999, Vol 17, Num 5, pp 1535-1544, issn 0732-183XArticle

Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factorBROSSART, P; GRÜNEBACH, F; STUHLER, G et al.Blood. 1998, Vol 92, Num 11, pp 4238-4247, issn 0006-4971Article

Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapiesBROSSART, P; HEINRICH, K. S; STUHLER, G et al.Blood. 1999, Vol 93, Num 12, pp 4309-4317, issn 0006-4971Article

Direct identification of major histocompatibility complex class I-bound tumor-associated peptide antigens of a renal carcinoma cell line by a novel mass spectrometric methodFLAD, T; SPENGLER, B; KURZ, B et al.Cancer research (Baltimore). 1998, Vol 58, Num 24, pp 5803-5811, issn 0008-5472Article

Serum cytokine levels in cancer patients treated with different schedules of ultra-low-dose interleukin-2LINDEMANN, A; BROSSART, P; HÖFFKEN, K et al.Journal of immunotherapy. 1994, Vol 15, Num 3, pp 225-230, issn 1053-8550Article

A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclinesSCHMID, P; KÜHNHARDT, D; FREIER, W et al.Annals of oncology. 2008, Vol 19, Num 5, pp 871-876, issn 0923-7534, 6 p.Article

Proteasome inhibitors : antitumor effects and beyondNENCIONI, A; GRÜNEBACH, F; PATRONE, F et al.Leukemia. 2007, Vol 21, Num 1, pp 30-36, issn 0887-6924, 7 p.Article

Zoledronic acid inhibits the function of Toll-like receptor 4 ligand activated monocyte-derived dendritic cellsBRINGMANN, A; SCHMIDT, S. M; WECK, M. M et al.Leukemia. 2007, Vol 21, Num 4, pp 732-738, issn 0887-6924, 7 p.Article

Pre-clinical and early clinical experience using dendritic cells to treat human malignancyKANZ, L; BROSSART, P; STUHLER, G et al.Hematology and cell therapy (Print). 1999, Vol 41, Num 2, pp 56-57, issn 1269-3286Conference Paper

Determinants of survival in patients with brain metastases from cutaneous melanomaSTAUDT, M; LASITHIOTAKIS, K; LEITER, U et al.British journal of cancer. 2010, Vol 102, Num 8, pp 1213-1218, issn 0007-0920, 6 p.Article

Characterization of BAX inhibitor-1 as a novel leukemia-associated antigenSCHMIDT, S. M; KÖNIG, T; BRINGMANN, A et al.Leukemia. 2009, Vol 23, Num 10, pp 1818-1824, issn 0887-6924, 7 p.Article

T-cell receptor β variable region diversity in melanoma metastases after interleukin 2-based immunotherapyWILLHAUCK, M; MÖHLER, T; SCHEIBENBOGEN, C et al.Clinical cancer research. 1996, Vol 2, Num 4, pp 767-772, issn 1078-0432Article

Detection of residual tumor cells in patients with malignant melanoma responding to immunotherapyBROSSART, P; KEILHOLZ, U; SCHEIBENBOGEN, C et al.Journal of immunotherapy. 1994, Vol 15, Num 1, pp 38-41, issn 1053-8550Article

Detection of a new JAK2 D620E mutation in addition to V617F in a patient with polycythemia veraGRÜNEBACH, F; BROSS-BACH, U; KANZ, L et al.Leukemia. 2006, Vol 20, Num 12, pp 2210-2211, issn 0887-6924, 2 p.Article

Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II studyBRUGGER, W; HIRSCH, J; KAUFMANN, M et al.Annals of oncology. 2004, Vol 15, Num 11, pp 1691-1698, issn 0923-7534, 8 p.Article

Anticancer vaccination strategiesNENCIONI, A; GRÜNEBACH, F; PATRONE, F et al.Annals of oncology. 2004, Vol 15, pp iv153-iv160, issn 0923-7534, SUP4Conference Paper

Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytesGRÜNEBACH, F; MÜLLER, M. R; NENCIONI, A et al.Gene therapy (Basingstoke). 2003, Vol 10, Num 5, pp 367-374, issn 0969-7128, 8 p.Article

Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytesBROSSART, P; STUHLER, G; FLAD, T et al.Cancer research (Baltimore). 1998, Vol 58, Num 4, pp 732-736, issn 0008-5472Article

Hematogenous spread of malignant melanoma cells in different stages of diseaseBROSSART, P; KEILHOLZ, U; WILLHAUCK, M et al.Journal of investigative dermatology. 1993, Vol 101, Num 6, pp 887-889, issn 0022-202XArticle

Direct effects of protirelin (TRH) on cultured porcine thyrocytesWAHL, R; BROSSART, P; EIZENBERGER, D et al.Journal of endocrinological investigation (Testo stampato). 1992, Vol 15, Num 5, pp 345-351, issn 0391-4097Article

Successful management of Candida krusei monoarthritis after allo-SCTMAYER, K; KAPELLE, M; KAEFERSTEIN, A et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 12, pp 1585-1586, issn 0268-3369, 2 p.Article

Immunomodulatory effects of anti-angiogenic drugsHEINE, A; HELD, Sae; BRINGMANN, A et al.Leukemia. 2011, Vol 25, Num 6, pp 899-905, issn 0887-6924, 7 p.Article

Post-transcriptional regulation of adapter molecules by IL-10 inhibits TLR-mediated activation of antigen-presenting cellsKNÖDLER, A; SCHMIDT, S. M; BRINGMANN, A et al.Leukemia. 2009, Vol 23, Num 3, pp 535-544, issn 0887-6924, 10 p.Article

Tumor necrosis factor α and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cellsBROSSART, P; ZOBYWALSKI, A; GRÜNEBACH, F et al.Cancer research (Baltimore). 2000, Vol 60, Num 16, pp 4485-4492, issn 0008-5472Article